Sonoma Pharmaceuticals (SNOA) Change in Accured Expenses (2016 - 2025)
Sonoma Pharmaceuticals has reported Change in Accured Expenses over the past 16 years, most recently at -$362000.0 for Q4 2025.
- For Q4 2025, Change in Accured Expenses fell 552.5% year-over-year to -$362000.0; the TTM value through Dec 2025 reached -$196000.0, down 150.65%, while the annual FY2025 figure was $194000.0, 921.05% up from the prior year.
- Change in Accured Expenses for Q4 2025 was -$362000.0 at Sonoma Pharmaceuticals, down from $598000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $598000.0 in Q3 2025 and troughed at -$484000.0 in Q2 2025.
- A 5-year average of $44100.0 and a median of $52500.0 in 2024 define the central range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 6544.44% in 2025 and fell as far as 1013.21% in 2025.
- Year by year, Change in Accured Expenses stood at $306000.0 in 2021, then increased by 27.45% to $390000.0 in 2022, then crashed by 184.62% to -$330000.0 in 2023, then surged by 124.24% to $80000.0 in 2024, then crashed by 552.5% to -$362000.0 in 2025.
- Business Quant data shows Change in Accured Expenses for SNOA at -$362000.0 in Q4 2025, $598000.0 in Q3 2025, and -$484000.0 in Q2 2025.